TREM2 Is Associated with Advanced Stages and Inferior Prognosis in Oral Squamous Cell Carcinoma

SIMPLE SUMMARY: Triggering receptor expressed on myeloid cells 2 (TREM2) is an appealing candidate for immunotherapy. However, results regarding its role in multiple cancers are rare or even contradictory. We showed that TREM2 expression in immune cells, among which were macrophages in peripheral bl...

Descripción completa

Detalles Bibliográficos
Autores principales: Struckmeier, Ann-Kristin, Radermacher, Anne, Fehrenz, Michael, Alansary, Dalia, Wartenberg, Philipp, Wagner, Mathias, Scheller, Anja, Hess, Jochen, Moratin, Julius, Freudlsperger, Christian, Hoffmann, Jürgen, Thurner, Lorenz, Roemer, Klaus, Freier, Kolja, Horn, Dominik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561992/
https://www.ncbi.nlm.nih.gov/pubmed/36230558
http://dx.doi.org/10.3390/cancers14194635

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561992/
https://www.ncbi.nlm.nih.gov/pubmed/36230558
http://dx.doi.org/10.3390/cancers14194635

Ejemplares similares